Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.30 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13436141 | 1.00 | CA12 (0.42) | CA12CA2CA3CA4CA6 | |
| SCHEMBL19212991 | 0.89 | CYP2C9 (0.36) | CA12CA2CA3CA4CA6 | |
| SCHEMBL28594961 | 0.87 | MAPT (0.50) | CA12CA2CA3CA4CA6 | |
| SCHEMBL8345764 | 0.86 | CYP2C9 (0.37) | CA12CA2CA3CA4CA6 | |
| SCHEMBL19212961 | 0.85 | CA12 (0.43) | CA12CA2CA3CA4CA6 | |
| SCHEMBL14423579 | 0.83 | PRMT3 (0.54) | CA12CA2CA3CA4CA6 | |
| SCHEMBL12794518 | 0.83 | CA12 (0.57) | CA12CA2CA3CA4CA6 | |
| SCHEMBL15444951 | 0.83 | CA12 (0.57) | CA12CA2CA3CA4CA6 | |
| SCHEMBL82581 | 0.83 | CA12 (0.57) | CA12CA2CA3CA4CA6 | |
| SCHEMBL224384 | 0.83 | LCK (0.46) | LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117801262-A | Leveling agent, electroplating composition and application thereof | 华为技术有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023141576-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | POSEIDA THERAPEUTICS, INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| US-20130041148-A1 | PROCESS FOR THE SYNTHESIS OF N-ALKOXYAMINES | BASF SE (DE) | 2013-02-14 | — | — | US | disclosed |
| EP-1501881-A1 | POLYMERS PRODUCED BY ATOM TRANSFER RADICAL POLYMERISATION TECHNIQUE WITH STRUCTURALLY MODIFIED TERMINAL GROUPS | Ciba Specialty Chemicals Holding Inc. (CH) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003095512-A1 | POLYMERS PRODUCED BY ATOM TRANSFER RADICAL POLYMERISATION TECHNIQUE WITH STRUCTURALLY MODIFIED TERMINAL GROUPS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-11-20 | — | — | WO | disclosed |
| US-20030105201-A1 | Pigment compositions with modified block copolymer dispersants | CIBA SPECIALTY CHEMICALS CORP. | 2003-06-05 | — | — | US | disclosed |
| EP-0790986-B1 | ANILINE DERIVATIVES | ZENECA LTD (GB) | 1999-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041148-A1 | PROCESS FOR THE SYNTHESIS OF N-ALKOXYAMINES | PNMT, PAH, PAOX | CA12 4521/4885CA2 4159/4885CA3 4512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.